Found 473 results for purchase-new-york

Deal Toys Deconstructed: See What a New Documentary Reveals

February 9, 2015 by David Parry

A new documentary offers an outsider’s perspective on not only the nature of deal toys, but also...

 Blog Post

Newsy/Scripps Custom iPhone Lucite

Custom Lucite recognizing the acquisition of Columbia, Missouri-based video news provider Newsy by Scripps. Headquartered in Cincinnati, Ohio, Scripps owns 19 local television stations and daily newspapers in 13 markets across the U.S.

1 Image

Australia and New Zealand Deal Toys: A Gallery of Recent Highlights

January 8, 2016 by David Parry

Most bankers love looking at deal toys. Particularly those done by rival banks…and even if...

 Blog Post

Vodafone New Zealand Deal Tombstone

Crystal deal tombstone marking the sale of Vodafone New Zealand, New Zealand’s largest mobile company. The acquirers were Infratil, a New Zealand-based investment company, and Brookfield Asset Management, a Canadian firm.

(9LJW171)
1 Image

Pepsi Financial Tombstone

Financial tombstone deal toy celebrating the acquisition by PepsiCo, headquartered in Purchase, New York, of Amacoco Nordeste Ltda. and Amacoco Sudeste Ltda. two brands based in Brazil.

1 Image

The Missing Moon Rock…and 7 Other Bizarre Lucite Stories

March 23, 2015 by David Parry

We tend to think of Lucite in terms of its virtues--- as that versatile, durable, malleable...

 Blog Post

Ringing the Bell: IPO Deal Toys and Deal Gifts

January 19, 2022 by David Parry

Along with mergers & acquisitions, initial public offerings provide some of the most common...

 Blog Post

The Deal Tombstone Backstory: A Megadeal Signed at a Food Stamps Office

November 10, 2023 by David Parry

In our 42-year history, The Corporate Presence has designed the deal tombstone for a number of...

 Blog Post

New Drug Application Custom Crystal

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

(20ALJ356)
2 Images
Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches.